Hirtle Callaghan & Co’s Cigna CI Stock Holding History

Hirtle Callaghan & Co’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-540	Closed	-$56K	–	75
2014 Q4	$56K	Hold	540	–	–	0.01%	284
2014 Q3	$49K	Hold	540	–	–	0.01%	304
2014 Q2	$50K	Hold	540	–	–	0.01%	358
2014 Q1	$45K	Hold	540	–	–	0.01%	359
2013 Q4	$47K	Hold	540	–	–	0.01%	340
2013 Q3	$42K	Buy	+540	New	+$42.2K	0.01%	363

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Hirtle Callaghan & Co's CI Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Cigna (CI) in Q1 2015, closing a stake of 540 shares — an estimated $56K sold.

Hirtle Callaghan & Co first reported a position in CI in Q3 2013 and held it in 6 quarters. The position peaked at $56K in Q4 2014. 690 funds tracked by Wall St. Rank hold CI as of Q1 2015.

Hirtle Callaghan & Co reported no remaining Cigna position as of Q1 2015 after selling out during the quarter.
Hirtle Callaghan & Co sold 540 Cigna shares in Q1 2015, an estimated $56K.
Hirtle Callaghan & Co first reported a position in Cigna in Q3 2013 and held it in 6 quarters.
Hirtle Callaghan & Co's Cigna position peaked at $56K in Q4 2014.
690 funds tracked by Wall St. Rank held Cigna as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.